Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis

Trial Profile

Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jan 2017

At a glance

  • Drugs Iguratimod (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Sponsors Eisai Co Ltd
  • Most Recent Events

    • 15 Dec 2016 Status changed from active, no longer recruiting to completed.
    • 14 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top